Literature DB >> 25900782

Efficiency, satisfaction, and costs for remote video visits following radical prostatectomy: a randomized controlled trial.

Boyd R Viers1, Deborah J Lightner1, Marcelino E Rivera1, Matthew K Tollefson1, Stephen A Boorjian1, R Jeffrey Karnes1, R Houston Thompson1, Daniel A O'Neil2, Rachel L Hamilton2, Matthew R Gardner2, Mary Bundrick2, Sarah M Jenkins3, Sandhya Pruthi2, Igor Frank1, Matthew T Gettman4.   

Abstract

BACKGROUND: Telemedicine in an ambulatory surgical population remains incompletely evaluated.
OBJECTIVE: To investigate patient encounters in the outpatient setting using video visit (VV) technology compared to traditional office visits (OVs). DESIGN, SETTING, AND PARTICIPANTS: From June 2013 to March 2014, 55 prescreened men with a history of prostate cancer were prospectively randomized. VVs, with the patient at home or at work, were included in the outpatient clinic calendar of urologists. INTERVENTION: Remote VV versus traditional OV. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: An equivalence analysis was used to assess the primary outcome, visit efficiency as measured by time studies. Secondary outcomes were patient/provider satisfaction and costs. RESULTS AND LIMITATIONS: There were 28 VVs and 27 OVs. VVs were equivalent in efficiency to relative to OVs, as measured by patient-provider face time (mean 14.5 vs 14.3min; p=0.96), patient wait time (18.4 vs 13.0min; p=0.20), and total time devoted to care (17.9 vs 17.8min; p=0.97). There were no significant differences in patient perception of visit confidentiality, efficiency, education quality, or overall satisfaction. VVs incurred lower costs, including distance traveled (median 0 vs 95 miles), travel time (0 vs 95min), missed work (0 vs 1 d), and money spent on travel ($0 vs $48; all p<0.0001). There was a high level of urologist satisfaction for both VVs (88%) and OVs (90%). The major limitation was sample size.
CONCLUSIONS: VV in the ambulatory postprostatectomy setting may have a future role in health care delivery models. We found equivalent efficiency, similar satisfaction, but significantly reduced patient costs for VV compared to OV. Further prospective analyses are warranted. PATIENT
SUMMARY: Among men with surgically treated prostate cancer, we evaluated the utility of remote video visits compared to office visits for outpatient consultation with a urologist. Video visits were associated with equivalent efficiency, similar satisfaction, and significantly lower patient costs when compared to office visits. We conclude that video visits may have a future role in health care delivery models.
Copyright © 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Patient acceptance; Patient perception; Randomized controlled trial; Teleconsultation; Telehealth; Telemedicine; Urology; Video visits

Mesh:

Year:  2015        PMID: 25900782     DOI: 10.1016/j.eururo.2015.04.002

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  71 in total

Review 1.  Telemedicine and prostate cancer survivorship: a narrative review.

Authors:  Nnenaya Q Agochukwu; Ted A Skolarus; Daniela Wittmann
Journal:  Mhealth       Date:  2018-10-08

Review 2.  Urological technology: where will we be in 20 years' time?

Authors:  Darryl Ethan Bernstein; Brett Sydney Bernstein
Journal:  Ther Adv Urol       Date:  2018-06-17

3.  Telehealth Delivery of Outpatient Pediatric Surgical Care in Hawai'i: An Opportunity Analysis.

Authors:  Nicole R Laferriere; Michele Saruwatari; Xuan-Lan Doan; Kelli B Ishihara; Devin P Puapong; Sidney M Johnson; Russell K Woo
Journal:  Hawaii J Health Soc Welf       Date:  2020-05-01

4.  Feasibility of an Image-Based Mobile Health Protocol for Postoperative Wound Monitoring.

Authors:  Rebecca L Gunter; Sara Fernandes-Taylor; Shahrose Rahman; Lola Awoyinka; Kyla M Bennett; Sharon M Weber; Caprice C Greenberg; K Craig Kent
Journal:  J Am Coll Surg       Date:  2018-01-19       Impact factor: 6.113

5.  Patient Perceptions of Telehealth Primary Care Video Visits.

Authors:  Rhea E Powell; Jeffrey M Henstenburg; Grace Cooper; Judd E Hollander; Kristin L Rising
Journal:  Ann Fam Med       Date:  2017-05       Impact factor: 5.166

6.  Patient preferences on the use of technology in cancer surveillance after curative surgery: A cross-sectional analysis.

Authors:  Amblessed E Onuma; Elizabeth Palmer Kelly; Jeffery Chakedis; Anghela Z Paredes; Diamantis I Tsilimigras; Brianne Wiemann; Morgan Johnson; Katiuscha Merath; Ozgur Akgul; Jordan Cloyd; Timothy M Pawlik
Journal:  Surgery       Date:  2019-02-13       Impact factor: 3.982

Review 7.  Current Use of Telemedicine for Post-Discharge Surgical Care: A Systematic Review.

Authors:  Rebecca L Gunter; Skyler Chouinard; Sara Fernandes-Taylor; Jason T Wiseman; Sam Clarkson; Kyla Bennett; Caprice C Greenberg; K Craig Kent
Journal:  J Am Coll Surg       Date:  2016-02-13       Impact factor: 6.113

Review 8.  Current use of telehealth in urology: a review.

Authors:  Peris Castaneda; Chad Ellimoottil
Journal:  World J Urol       Date:  2019-07-27       Impact factor: 4.226

9.  Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial).

Authors:  B K Bednarski; T P Nickerson; Y N You; C A Messick; B Speer; V Gottumukkala; M Manandhar; M Weldon; E M Dean; W Qiao; X Wang; G J Chang
Journal:  Br J Surg       Date:  2019-06-19       Impact factor: 6.939

10.  A prospective, multisite study analyzing the percentage of urological cases that can be completely managed by telemedicine.

Authors:  Bruno Turcotte; Sophie Paquet; Anne-Sophie Blais; Annie-Claude Blouin; Stéphane Bolduc; Michel Bureau; Yves Caumartin; Jonathan Cloutier; Marie-Pier Deschênes-Rompré; Thierry Dujardin; Yves Fradet; Louis Lacombe; Katherine Moore; Fannie Morin; Geneviève Nadeau; David Simonyan; Frédéric Soucy; Rabi Tiguert; Paul Toren; Michele Lodde; Frédéric Pouliot
Journal:  Can Urol Assoc J       Date:  2020-10       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.